This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fontaine, L.
Right arrow Articles by Hols, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fontaine, L.
Right arrow Articles by Hols, P.
Agricola
Right arrow Articles by Fontaine, L.
Right arrow Articles by Hols, P.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, February 2008, p. 1102-1110, Vol. 74, No. 4
0099-2240/08/$08.00+0     doi:10.1128/AEM.02030-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

The Inhibitory Spectrum of Thermophilin 9 from Streptococcus thermophilus LMD-9 Depends on the Production of Multiple Peptides and the Activity of BlpGSt, a Thiol-Disulfide Oxidase{triangledown} ,{dagger}

Laetitia Fontaine and Pascal Hols*

Unité de Génétique, Institut des Sciences de la Vie, Université catholique de Louvain, Place Croix du Sud 5, B-1348 Louvain-la-Neuve, Belgium

Received 5 September 2007/ Accepted 10 December 2007


arrow
ABSTRACT
 
The blpSt cluster of Streptococcus thermophilus LMD-9 was recently shown to contain all the genetic information required for the production of bacteriocins active against other S. thermophilus strains. In this study, we further investigated the antimicrobial activity of S. thermophilus LMD-9 by testing the susceptibility of 31 bacterial species (87 strains). We showed that LMD-9 displays an inhibitory spectrum targeted toward related gram-positive bacteria, including pathogens such as Listeria monocytogenes. Using deletion mutants, we investigated the contribution of the three putative bacteriocin-encoding operons blpDSt-orf2, blpUSt-orf3, and blpESt-blpFSt (bacSt operons) and of the blpGSt gene, which encodes a putative modification protein, to the inhibitory spectrum and immunity of strain LMD-9. Our results present evidence that the blpSt locus encodes a multipeptide bacteriocin system called thermophilin 9. Among the four class II bacteriocin-like peptides encoded within the bacSt operons, BlpDSt alone was sufficient to inhibit the growth of most thermophilin 9-sensitive species. The blpDSt gene forms an operon with its associated immunity gene(s), and this functional bacteriocin/immunity module could easily be transferred to Lactococcus lactis. The remaining three BacSt peptides, BlpUSt, BlpESt, and BlpFSt, confer poor antimicrobial activity but act as enhancers of the antagonistic activity of thermophilin 9 by an unknown mechanism. The blpGSt gene was also shown to be specifically required for the antilisteria activity of thermophilin 9, since its deletion abolished the sensitivities of most Listeria species. By complementation of the motility deficiency of Escherichia coli dsbA, we showed that blpGSt encodes a functional thiol-disulfide oxidase, suggesting an important role for disulfide bridges within thermophilin 9.


arrow
INTRODUCTION
 
Bacteriocins are small (20- to 60-residue) ribosomally synthesized and extracellularly released peptides displaying antimicrobial activity against species that may or may not be closely related to the producer bacteria (24). Generally, bacteriocin producer strains secrete multiple antimicrobial peptides, each exhibiting a specific inhibitory spectrum, which provides the producer strain with a competitive advantage by eliminating concurrent strains (or species) sharing the same ecological niche. Well-known examples are the production by Streptococcus mutans of mutacins (five mutacins have been identified so far), which are active against streptococcal species present in the human oral cavity (19, 23), and the production by Lactobacillus sakei LTH673 of sakacin P, which has the greatest activity against Carnobacterium and Listeria species (39), and sakacin Q, mainly active against Lactobacillus coryniformis (31). The last decade has seen a growing interest in the bacteriocins of lactic acid bacteria (LAB), particularly those active against clostridia, listeria, and enteropathogen species, because of their potential use as natural biopreservatives to protect food products against bacterial contamination.

Streptococcus thermophilus is of major importance for the food industry, since it is widely used for the manufacture of dairy products (with an annual market of around $40 billion), and it is considered the second most important industrial dairy starter after Lactococcus lactis (22). In S. thermophilus LMD-9, the production of bacteriocin-like inhibitory substances active against other strains of S. thermophilus has recently been shown to depend on the chromosomally encoded class II blpSt locus (15). The class II bacteriocins of LAB include non-posttranslationally modified peptides (36) and are further subdivided into three main subcategories: IIa, the pediocin-like bacteriocins with strong antilisterial effects, which contain a conserved N-terminal YGNGVXC sequence (12), and IIb, bacteriocins whose activities depend on the complementary activities of two peptides ({alpha} and β peptides) (18). All other nonmodified bacteriocins are classified as class IIc (36). Class II bacteriocins of LAB permeabilize the target cell membrane by the formation of poration complexes, which leads to the release of essential molecules and the dissipation of the proton motive force (20).

As is the case for the production of many bacteriocins by LAB, the BlpSt-related antimicrobial activity of S. thermophilus is regulated at the transcriptional level by a cell-density mechanism (quorum sensing) (15, 25). The pheromone precursor BlpCSt is processed downstream of a double-glycine (two-Gly) motif and secreted through a specific transport apparatus consisting of the ABC transporter BlpASt and the accessory protein BlpBSt (15). The processed forms of BlpCSt (D9C-30 [30 amino acids {aa}] and D9C-19 [19 aa]) activate a signaling cascade involving the BlpHSt/BlpRSt two-component system, which triggers the transcription of the bacteriocin and immunity structural genes (15). These genes are organized into three operons (blpDSt-orf2, blpUSt-orf3, and blpESt-blpFSt), each comprising putative bacteriocin genes (collectively named bacSt genes) and orf genes (15). The four BacSt peptides BlpDSt, BlpUSt, BlpESt, and BlpFSt contain a two-Gly leader, which is likely cleaved off during secretion by the BlpABSt transport system. However, their individual functionalities and their putative interactions as a multipeptide bacteriocin remained hypothetical (15). The Orf peptides and the predicted mature BacSt peptides, except for the mature peptide BlpFSt* (the asterisk represents the putative mature part of the peptide, i.e., after cleavage downstream of the first two-Gly motif), contain stretches of highly hydrophobic residues that are predicted to form transmembrane segments (Table 1). The predicted mature peptides BlpDSt*, BlpUSt*, and BlpESt* contain several Gly-Gly, Ala-Gly, and Gly-Ala repeats, which is typical of two-component class IIb bacteriocins (Table 1). Additionally, BlpESt*, BlpUSt*, and BlpDSt* share 28, 28, and 29% identity (44, 36, and 51% similarity) with the β peptide of lactococcin M, the {alpha} peptide of thermophilin 13, and the β peptide of brochocin C, respectively (30, 33, 35).


View this table:
[in this window]
[in a new window]

 
TABLE 1. Primary sequence analysis of the BacSt and Orf peptides encoded in the blpDSt-blpFSt region

The predicted processed forms of the four BacSt peptides contain two cysteine residues at their N- and C-terminal ends. Recent studies have highlighted a strong correlation between the toxicity of class IIa bacteriocins and the number of disulfide bridges formed, which might play a role in their structural stability (11, 37). Intriguingly, the blpGSt-blpXSt operon, which is also regulated by the BlpCSt pheromone, encodes a putative modification protein (BlpGSt) with a thioredoxin fold domain containing the conserved thioredoxin catalytic motif CXXC. In Bacillus subtilis, the BdbB thiol-disulfide oxidase was shown to be required for the production of active sublancin 168, a bacteriocin that contains two disulfide bridges (9). Although the blpGSt-blpXSt operon of S. thermophilus does not seem to be required for the intraspecies antimicrobial activity of strain LMD-9 (15), its potential role in the inhibition of other species has not been investigated.

The aim of this study was to identify the genetic determinants involved in the BlpSt-related antimicrobial activity and immunity of S. thermophilus LMD-9 by genetic dissection of the blpSt locus and heterologous expression. We first determined the inhibitory spectrum of strain LMD-9 against a large set of indicator species. Appropriate blpSt mutants were then constructed, and their antimicrobial activities and immunity phenotypes were investigated.


arrow
MATERIALS AND METHODS
 
Bacterial strains, plasmids, and growth conditions.
The bacterial strains and plasmids used in the present study, except for the indicator bacteria used to determine the antimicrobial spectrum of S. thermophilus LMD-9, are listed in Table 2. Escherichia coli was grown with shaking at 37°C in Luria-Bertani (LB) broth (38). E. coli motility was assayed on swarm plates containing 1% Bacto tryptone (wt/vol), 0.5% NaCl (wt/vol), and 0.3% agar (wt/vol), as previously described (3). Swarm plates were inoculated with 5 µl of exponentially growing cultures (optical density at 600 nm [OD600], 1.0) of E. coli and incubated at 37°C for 20 h. S. thermophilus was grown anaerobically (BBL GasPak systems; Becton Dickinson, Franklin Lakes, NJ) in M17 broth (Difco Laboratories Inc., Detroit, MI) with 1% (wt/vol) glucose (M17G broth) at 42°C. L. lactis was grown in M17 broth with 0.5% (wt/vol) glucose at 29°C without shaking. When appropriate, erythromycin was added to the media at the following concentrations: 250 µg/ml for E. coli, 2.5 µg/ml for S. thermophilus, and 5 µg/ml for L. lactis. Solid agar plates were prepared by adding 2% (wt/vol) agar to the media.


View this table:
[in this window]
[in a new window]

 
TABLE 2. Bacterial strains and plasmids used in this study

DNA techniques and transformation.
General molecular biology techniques were performed according to the instructions given by Sambrook et al. (38). Plasmids derived from pMG36e (40) and pGhost9 (28) were constructed in E. coli strains TG1 (38) and EC1000 (26), respectively. Electrotransformation of E. coli, S. thermophilus, and L. lactis was performed as described by Dower et al. (10), Blomqvist et al. (4), and Leenhouts et al. (27), respectively. The transformed S. thermophilus cells were immediately resuspended in 1 ml of M17G and were incubated anaerobically for 6 h at 37°C (pMG36e derivatives) or 29°C (pGhost9 derivatives). Chromosomal DNAs of S. thermophilus and Lactobacillus plantarum were prepared as described previously (13). PCRs were performed with Pfu DNA polymerase (Promega, Madison, WI) in a GeneAmp PCR system 2400 (Applied Biosystems, Lennik, Belgium).

Construction of the blpGSt expression vector.
The entire open reading frame (ORF) of blpGSt was amplified by PCR with primers BlpG1 (5'-AAACCATGGTGAAAAAAAGGACATTAACGC-3') and BlpG2 (5'-CGGGTACCTTCTCTTTCGTACTCTCTTCG-3'), yielding a 0.69-kb fragment that was then digested with NcoI and KpnI (the restriction sites are underlined in the primer sequences) and translationally fused with the P32 expression signals into the similarly digested pGIBG001 plasmid (15). The resulting plasmid was designated pGILF003.

Construction of the vectors for heterologous expression of BlpABSt and blpDSt-orf2 in L. lactis.
First, the ldhL transcriptional terminator from L. plantarum NCIMB8826 was PCR amplified using primers LdhTER1 (5'-AAAGCATGCACATCATCAACTTGAAGGG-3') and LdhTER2 (5'-ATACTGCCCCCAATCATAAGTCCACG-3'), digested with SphI (the restriction site is underlined in the LdhTER1 sequence) and KpnI (the restriction site present in the sequence of ldhL), and cloned into the similarly digested pMG36e vector (40), yielding pMG36eT. In a second step, a fragment encompassing the blpDSt ribosome binding site and the blpDSt-orf2 region was PCR amplified with primers pMGopD1 (5'-AAAGTCGACAAATTTTAGGAGGTAGTTGC-3') and pMGopD2 (5'-AACCTGCAGGCTAATTCTTTCTATACTGCC-3'), digested with SalI and PstI (the restriction sites are underlined in the primer sequences), and transcriptionally fused with the P32 promoter into the similarly digested pMG36eT vector, yielding plasmid pGILF004. Finally, a PCR fragment encompassing the blpASt ribosome binding site and the blpABSt genes, obtained with primers BlpAB1 (5'-AACCTGCAGGATAATTTGTGATGAAAGGG-3') and BlpAB2 (5'-AAAGCATGCTTAGCCATCAGTAATTCTCC-3'), was digested with SbfI and SphI (the restriction sites are underlined in the primer sequences) and cloned between the corresponding sites of plasmid pGILF004, downstream of the blpDSt-orf2 operon. In the resulting plasmid, pGILF005, the blpDSt-orf2 operon and the blpABSt genes formed an artificial operon structure whose transcription was controlled by the P32 promoter.

Construction of deletion mutants in the blpSt locus.
The deletion vectors were constructed in the thermosensitive pGhost9 vector by successively cloning two fragments of approximately 1 kb, corresponding to the upstream and downstream regions of the target gene(s), respectively. Deletions were performed by a two-step homologous-recombination process, as previously described (29). Both recombination steps (plasmid integration and excision) were confirmed by PCR using primers located upstream and downstream of the recombination regions. Table S1 in the supplemental material gives an overview of the strategy used for the construction of the different deletion vectors and the corresponding S. thermophilus mutant strains.

Analysis of the antimicrobial activities and immunities of LMD-9 derivatives.
The synthetic mature form of BlpCSt, named D9C-30 (H2N-SGWMDYINGFLKGFGGQRTLPTKDYNIPQA-COOH) (purity > 95%), was purchased from Sigma-Genosys (Sigma-Genosys Ltd., Haverhill, United Kingdom). Two alternative methods were used to assay antimicrobial activity, as previously described (15). For the spot-on-lawn method, overnight cultures of the producer strains were diluted 100-fold in fresh M17G broth and incubated anaerobically at 42°C. At an OD600 of 0.1, the synthetic D9C-30 peptide was added at a final concentration of 400 ng/ml, and the cultures were then reincubated for 2 h (final OD600, 1.6). Small volumes (5 µl) of the induced cultures were then spotted directly on a 6-ml soft M17G layer (0.8% agar) containing 108 CFU of indicator strains. The plates were incubated anaerobically at 42°C overnight before analysis of the inhibition zones surrounding the producer cells. For the overlay method (multilayer method), overnight cultures of S. thermophilus or L. lactis producer strains were diluted 100-fold in fresh M17G broth and incubated anaerobically at 42°C (S. thermophilus) or at 29°C (L. lactis). At an OD600 of 1.0, 100 µl of the cultures was diluted 106-fold in 6 ml of prewarmed soft M17G medium (0.8% agar) and uniformly poured on a petri dish containing a supporting layer of 25 ml solid M17G medium (2% agar). A second 6-ml soft M17G layer containing 400 ng/ml D9C-30 was poured on the layer of producer cells. Following growth of the producer strain (10 h of incubation), a third 6-ml layer of soft medium containing 108 CFU of the indicator strain was added. The plates were incubated for 10 h before analysis of the inhibition zones surrounding the producer colonies. The composition of the growth medium used for the layer of indicator cells, as well as the incubation conditions, was adapted according to the indicator species: strains of Streptococcus salivarius were grown anaerobically in M17G broth at 42°C, strains of Enterococcus faecalis were grown in M17 with 0.5% (wt/vol) glucose at 37°C, strains of Lactobacillus (29°C, aerobically) and Clostridium (37°C, anaerobically) were grown in MRS broth (Difco), strains of Bacillus (29°C, aerobically, for Bacillus fusiformis, Bacillus cereus, Bacillus licheniformis, Bacillus mycoides, and Bacillus thuringiensis; 42°C, anaerobically, for Bacillus coagulans) were grown in LB broth, and strains of Staphylococcus, Enterobacter, Micrococcus luteus, Salmonella, and Listeria were grown in LB broth in the presence of oxygen at 37°C. The strains of Staphylococcus, Enterobacter, Salmonella, Listeria, B. fusiformis, B. cereus, B. licheniformis, B. mycoides, B. thuringiensis, Micrococcus luteus, Enterobacter gergovia, Escherichia hermannii, Pseudomonas aeruginosa, and Salmonella enterica subsp. enterica serovar Bredeney were from the bacterial collection of the Unité de Microbiologie of the Université catholique de Louvain (Louvain-la-Neuve, Belgium).


arrow
RESULTS
 
Inhibitory spectrum of S. thermophilus LMD-9.
To date, BlpSt-associated antimicrobial activity of S. thermophilus LMD-9 has been reported to inhibit the growth of other S. thermophilus strains (15). Here, we further investigated the inhibitory spectrum of strain LMD-9 upon expression of the blpSt locus (400 ng/ml of the BlpCSt* pheromone, D9C-30); the susceptibilities of a range of bacterial strains were assayed using a multilayer protocol, as described previously (15). In total, 87 strains belonging to 31 bacterial species were tested as indicator strains. Among these, growth inhibition was observed for 33 strains, including all strains of S. thermophilus except LMG7952 and strains belonging to the closely related species S. salivarius, E. faecalis, and L. lactis (Table 3). Other species of LAB involved in food fermentations, such as L. plantarum, L. sakei, Lactobacillus curvatus, Lactobacillus fermentum, Lactobacillus casei, and Pediococcus pentosaceus were found to be resistant. Interestingly, Lactobacillus delbrueckii subsp. bulgaricus and Lactobacillus helveticus, used in cofermentations with S. thermophilus for the production of yogurt and cheese, respectively, were also not inhibited (Table 3). None of the gram-negative species tested (E. gergovia, E. coli, E. hermannii, P. aeruginosa, and S. enterica subsp. enterica serovar Bredeney) displayed sensitivity to the antimicrobial compounds produced by S. thermophilus LMD-9 (data not shown). Similarly, no antimicrobial activity was detected against the more distantly related gram-positive species Staphylococcus aureus, Staphylococcus hominis, Clostridium acetobutylicum, B. cereus, B. thuringiensis, B. licheniformis, B. mycoides, and M. luteus (data not shown). Notably, a number of exceptions were observed: S. thermophilus LMD-9 was found to inhibit the growth of the gram-positive species B. coagulans, B. fusiformis, and a number of Listeria species, including all strains of Listeria innocua and Listeria seeligeri, and of the pathogenic species Listeria monocytogenes and Listeria ivanovii (Table 3).


View this table:
[in this window]
[in a new window]

 
TABLE 3. Inhibitory spectrum of S. thermophilus LMD-9 and derivatives

Thermophilin 9 is a multipeptide bacteriocin.
The blpDSt-blpFSt region is organized into three operons encoding a total of four BacSt peptides (BlpDSt, BlpUSt, BlpESt, and BlpFSt) that show characteristics of class IIb bacteriocins (15). To confirm the implications of the three operons in the antimicrobial activity of strain LMD-9, the inhibitory spectrum of the {Delta}(blpDSt-blpFSt) mutant ({Delta}1) (Fig. 1A and Table 3) was investigated. As expected, none of the 33 LMD-9-sensitive strains was inhibited. This shows that the region encompassing the three operons is responsible not only for the intraspecies inhibition, as previously shown for S. thermophilus LMG18311 and CNRZ1066 (15), but also for the interspecies antimicrobial activity of LMD-9. The relative contributions of the different bacSt genes to this antimicrobial activity was then investigated by analyzing the inhibitory spectra of three mutant strains ({Delta}2, blpDSt+; {Delta}3, blpESt+ blpFSt+; {Delta}4/{Delta}5, blpUSt+) (Fig. 1A), each carrying only one of the three bacSt operons, under conditions of induction of the blpSt locus (400 ng/ml of D9C-30). This assay was performed exclusively with the 33 indicator strains that showed sensitivity to the wild-type LMD-9 strain (Table 3).


Figure 1
View larger version (20K):
[in this window]
[in a new window]

 
FIG. 1. Schematic representation of the genetic deletions performed in this study. Complete strain names and the corresponding genotypes are listed in Table 2. Genes encoding peptides with known or predicted functions are represented by patterned arrows: ABC transporter (small squares), accessory transport protein (large squares), induction factor (dark gray), response regulator (vertical lines), histidine kinase (horizontal lines), hydrophobic peptides of unknown function (black), hydrophilic peptides of unknown function (white), peptide similar to immunity proteins of class IIa bacteriocins (checkerboard squares), and modification protein (dots). Genes encoding the putative bacteriocins with a two-Gly leader are represented by light-gray arrows. The flags represent promoters, black flags for BlpCSt-induced promoters and gray flags for vegetative promoters. The hairpin structures indicate potential transcription terminators. The letters and numbers in italics refer to the corresponding blpSt and orf genes, respectively. (A) Deletions performed in the blpSt locus of strain LMD-9. (B) Deletions performed in the blpSt locus of strain LF109 [LMD-9 {Delta}(blpUSt-blpFSt)].

Strain {Delta}2, which contains only the blpDSt-orf2 operon, retained most of its antimicrobial activity; the cell target range and activity were only slightly attenuated compared to those of the wild-type strain (31/33 strains were inhibited). Growth inhibition of S. thermophilus SFi16 and L. lactis IL-1403 was lost, while the sizes of the inhibitory zones for the indicator strains L. lactis MG1363 and E. faecalis JH2-SS were significantly reduced (Tables 3 and 4). In contrast, the sole expression of the blpUSt-orf3 operon (strain {Delta}4/{Delta}5) failed to inhibit the growth of any of the 33 indicator strains (Table 3). The blpESt-blpFSt operon alone (strain {Delta}3) conferred a poor antimicrobial activity against S. thermophilus LMG18311, while growth of the remaining 32 indicator strains was not affected (Tables 3 and 4). These results strongly suggest that blpDSt encodes the key determinant of the antagonistic activity of strain LMD-9. To further validate this hypothesis, we determined the inhibitory spectra of strains {Delta}(blpDSt-orf2) ({Delta}4, blpUSt+ blpESt+ blpFSt+) and {Delta}blpDSt {Delta}(blpUSt-blpFSt) ({Delta}9, bacSt mutant and orf1+ orf2+) (Fig. 1A and B). As expected, neither of these two mutant strains inhibited growth of any of the LMD-9-sensitive strains, with the exception of S. thermophilus LMG18311, which displayed sensitivity to strain {Delta}4 (Table 3 and 4).


View this table:
[in this window]
[in a new window]

 
TABLE 4. Antimicrobial activities of S. thermophilus LMD-9 and derivatives against a defined set of indicator strains

The attenuated inhibitory spectrum and activity of strain {Delta}2 (blpDSt+) suggest that the growth inhibition of four LMD-9-sensitive strains (S. thermophilus SFi16, L. lactis IL-1403, L. lactis MG1363, and E. faecalis JH2-SS) relies on the coexpression of blpDSt together with blpUSt and/or blpEFSt. Strains {Delta}(blpESt-blpFSt) ({Delta}5, blpDSt+ blpUSt+) and {Delta}(blpUSt-orf6) ({Delta}6, blpDSt+ blpESt+ blpFSt+) were thus constructed in order to compare their inhibitory spectra to those of strains LMD-9 and {Delta}2 (blpDSt+). The results showed that the growth inhibition of L. lactis IL-1403 could occur only when both the blpDSt-orf2 and blpUSt-orf6 operons were expressed ({Delta}5) (Table 3), while the inhibition of E. faecalis JH2-SS required the coexpression of the blpDSt-orf2 and blpESt-blpFSt operons ({Delta}6) (Tables 3 and 4). Interestingly, the complete inhibition of S. thermophilus SFi16 and L. lactis MG1363 required the expression of all three bacSt operons (Tables 3 and 4).

Taken collectively, our results demonstrate that blpDSt is the main determinant of antimicrobial activity in S. thermophilus LMD-9 and that the coexpression of blpUSt and blpEFSt with blpDSt enhances the activity and cell target range of BlpDSt*. The BacSt peptides of S. thermophilus LMD-9 thus seem to be part of a multipeptide bacteriocin, which was named thermophilin 9.

BlpGSt is a functional disulfide oxidase required for the antilisterial activity of thermophilin 9.
We have shown previously that the blpGSt-blpXSt operon is not associated with intraspecies inhibition (15). Here, we investigated a possible role of these genes in the inhibition of indicator strains belonging to other species. Deletion of this operon [strain {Delta}(blpGSt-blpXSt), {Delta}7] (Fig. 1A) completely abolished the growth inhibition of six of the eight LMD-9-sensitive Listeria strains (Table 3). In addition, this mutant strain displayed decreased antimicrobial activity against five indicator strains (E. faecalis JH2-SS and JH2-2, L. monocytogenes IHE-92, B. coagulans NCIB8523, and L. lactis MG1363), as measured by the size of the inhibitory zone (Table 4). The role of the putative modification protein BlpGSt in the attenuated interspecies inhibitory activity of the mutant strain {Delta}7 was further investigated by constructing an in-frame deletion of blpGSt alone ({Delta}8) (Fig. 1A). As shown in Tables 3 and 4, the two mutant strains exhibited identical inhibitory spectra, thus revealing the specific role of BlpGSt in interspecies inhibition.

Besides the CYYC thioredoxin motif (Fig. 2A), BlpGSt (230 aa) contains a putative 27-aa signal sequence with a predicted cleavage probability of 1.0 (prediction by signalP). This suggests that the protein is released at the cell surface, where it might promote the formation of disulfide bonds in the antimicrobial compounds secreted by S. thermophilus LMD-9. To validate this hypothesis, we tested the ability of blpGSt to complement the motility deficiency of a dsbA-deficient mutant of E. coli AH50 (21), as previously described (3). DsbA is a periplasmic disulfide oxidase that catalyzes the formation of disulfide bridges in proteins of the flagellar machinery of E. coli (6). A blpGSt expression vector was constructed by cloning the blpGSt ORF downstream of the P32 expression cassette carried by an autoreplicative plasmid. As shown in Fig. 2B, expression of blpGSt was able to restore motility in the dsbA-deficient background, showing that BlpGSt is exported in the periplasmic space and is a functional thiol-disulfide oxidase.


Figure 2
View larger version (88K):
[in this window]
[in a new window]

 
FIG. 2. Functional role of BlpGSt. (A) Primary sequence alignment of the putative thioredoxin domains of BlpGSt from S. thermophilus LMD-9 and similar proteins (accession numbers: S. mutans UA159 Smu.1904c, NP722210; Brochothrix campestris ATCC 43754 BrcD, AAC95141; Lactobacillus salivarius UCC118 Orf1, AAM61773; B. subtilis 168 BdbB, CAB14062; E. coli K-12 DsbA, AAB02995). Blocks of conserved identical residues are shown on a black background. Amino acids showing conservation among all proteins are shown on a gray background. (B) Complementation of the motility deficiency of E. coli AH50 dsbA by expression of BlpGSt. Motility assays were performed on 0.3% agar-containing plates. The plates were incubated at 37°C for 20 h.

The functional role of orf genes in the innate immunity of S. thermophilus LMD-9.
In a previous study, we demonstrated that the genetic determinants of immunity against thermophilin 9 are located within the blpDSt-blpFSt region (15). Each bacSt gene was shown to be cotranscribed with one or more orf genes (Fig. 1A). These orf genes encode small peptides that display structural similarities (high pI and the presence of one to four predicted transmembrane segments) (Table 1) to the immunity peptides of the class IIb bacteriocins brochocin C and lacticin F (2, 33), supporting their potential roles in thermophilin 9 immunity. The absence of a signal peptide and a two-Gly leader sequence suggests that the products of the orf genes are located in the cell membrane. To investigate which of these orf genes is required for immunity, we first determined the impact of deleting each bacSt operon individually: the immunity phenotypes of mutants {Delta}4 (orf3+ to orf7+), {Delta}5 (orf1+ to orf6+), and {Delta}6 (orf1+ orf2+ orf7+) were determined against the induced thermophilin 9-producing strain LMD-9 using the spot-on-lawn method. Among the three indicator strains tested, only strain {Delta}6 displayed resistance against LMD-9 (Table 5), suggesting that orf7, together with orf1 and/or orf2, encodes the immunity determinants of thermophilin 9.


View this table:
[in this window]
[in a new window]

 
TABLE 5. Immunities of S. thermophilus LMD-9 and derivatives

We further investigated the immunity specificities of the orf1, orf2, and orf7 genes by comparing the resistances of strains {Delta}1 (no orf gene), {Delta}2 (orf1+ orf2+), and {Delta}3 (orf7+) against a set of LMD-9 derivatives producing only a subset of BacSt peptides: {Delta}4 (blpUSt+ blpESt+ blpFSt+), {Delta}6 (blpDSt+ blpESt+ blpFSt+), {Delta}5 (blpDSt+ blpUSt+), and {Delta}2 (blpDSt+). As shown in Table 5, all strains were able to grow when tested against strain {Delta}4, with the blpDSt-orf2 operon deleted, which supports the previous observation that BlpUSt* and BlpESt* BlpFSt* have no or poor antimicrobial activity, respectively. Reciprocally, expression of the blpDSt-orf2 operon alone (indicator strain {Delta}2) was sufficient to confer immunity to all producer strains tested ({Delta}2, {Delta}4, {Delta}5, and {Delta}6), provided that all four bacSt genes were not expressed together (producer strain LMD-9; Table 5). Since BlpDSt* is the main component of thermophilin 9 activity, these results suggest that orf1 and/or orf2 is specifically required for immunity against BlpDSt*, while the concomitant expression of orf7 is required against the antimicrobial activity resulting from a combination of BlpDSt* with BlpUSt* and BlpESt* BlpFSt*.

To specifically assess the function of orf1 in immunity to BlpDSt*, the resistance spectra of strains bearing either both orf1 and orf2 genes [{Delta}blpDSt {Delta}(blpUSt-blpFSt), {Delta}9] (Fig. 1B) or orf2 alone [{Delta}(blpDSt-orf1) {Delta}(blpUSt-blpFSt), {Delta}10] (Fig. 1B) were compared. As expected, strain {Delta}9 displayed a resistance spectrum identical to that of strain {Delta}2 (Table 5), showing that the BlpDSt* immunity determinants were efficiently expressed in a background devoid of blpDSt. The absence of orf1 (strain {Delta}10) resulted in the complete loss of immunity against all strains producing BlpDSt* (Table 5), confirming that at least orf1 is required in this process.

Heterologous production of BlpSt bacteriocins.
The main determinants of the antimicrobial activity and immunity of thermophilin 9 were shown to be encoded within the blpDSt-orf2 operon. In order to confirm these results, we tested the possibility of conferring BlpDSt-dependent antimicrobial activity to L. lactis by constitutive expression of the blpDSt-orf2 operon. The operon was cloned in transcriptional fusion with the vegetative promoter P32 carried by the multicopy plasmid pMG36eT (40). Introduction of this construct (plasmid pGILF004) into L. lactis NZ3900 did not result in the production of antimicrobial compounds active against the indicator strain S. thermophilus LMG18311, as assayed with the overlay protocol (Fig. 3). Growth inhibition of S. thermophilus LMG18311 could be achieved only through the coexpression of the blpDSt-orf2 operon with the transporter genes blpABSt in an artificial operon structure (plasmid pGILF005). L. lactis NZ3900(pGILF005) was active against the same strain carrying the cloning vector pMG36eT and against all LMD-9-sensitive S. thermophilus strains (data are shown only for LMG18311) (Fig. 3), except SFi16. This is consistent with the previous observation that all three bacSt operons are required for inhibition of strain SFi16 (Table 3). As for immunity, plasmid pGILF004 conferred resistance to the LMD-9 derivatives {Delta}5 (blpDSt+ blpUSt+) and {Delta}6 (blpDSt+ blpESt+ blpFSt+), but not against LMD-9 itself (blpDSt+ blpUSt+ blpESt+ blpFSt+) (data not shown). The immunity spectrum of NZ3900(pGILF005) was thus identical to that of the LMD-9 mutant bearing the blpDSt-orf2 operon alone ({Delta}2), confirming the finding that orf1 and orf2 are sufficient to protect against BlpDSt*.


Figure 3
View larger version (51K):
[in this window]
[in a new window]

 
FIG. 3. Antimicrobial activity of L. lactis NZ3900 containing the blpDSt-orf2 (pGILF004) or the blpDSt-orf2 and blpABSt expression vector (pGIL005) against the indicator strain S. thermophilus LMG18311 (overlay method).

These results demonstrate that the blpDSt-orf2 operon is a bacteriocin/immunity-encoding module able to fulfill its functions in the absence of other genes from S. thermophilus. However, efficient secretion and maturation of BlpDSt require a specific transport system encoded by blpABSt, which seems to have no functional counterpart in L. lactis.


arrow
DISCUSSION
 
S. thermophilus LMD-9 displays an inhibitory spectrum against gram-positive bacteria (10 sensitive species among 26 gram-positive species tested) and is mainly active against closely related species. Its cell target range was shown to depend on the secretion of at least three BacSt peptides and the activity of BlpGSt, a thiol-disulfide oxidase specifically required for the inhibition of Listeria species.

Among the bacSt genes, the sole expression of blpDSt was sufficient to inhibit most indicator strains. Its coexpression with the blpUSt- and blpESt-blpFSt-containing operons further increased the antimicrobial activity and cell target range of S. thermophilus LMD-9. The results obtained from our deletion analysis suggest that thermophilin 9 is a multicomponent bacteriocin whose activity results from the combination of BlpDSt* with BlpUSt*, BlpESt*, and/or BlpFSt*. In this context, the BlpDSt* and BlpUSt* BlpESt* BlpFSt* peptides, respectively, could be compared to the active ({alpha}) and nonactive (β) subunits of thermophilin 13 (30), brochocin C (33), or lactacin F (1), all belonging to the class IIb bacteriocins. Interestingly, coexpression of the genes encoding the {alpha} and β peptides of lacticin F from Lactobacillus johnsonii was also shown to expand its cell target range (1). For thermophilin 9, the combination of BacSt peptides required for optimal growth inhibition appears to depend on the indicator species and strain. The efficient antimicrobial activity of thermophilin 9 could result from the formation of pores consisting of the {alpha} peptide BlpDSt* and one or more of the β peptides BlpUSt*, BlpESt*, or BlpFSt*, as proposed for most two-component bacteriocins (18). Alternatively, the different BacSt peptides could act synergistically to form pores of complementary specificities, resulting in increased efficiency, similar to what has been hypothesized for the one-component lactococcins A and B (class IIc) and the two-component lactococcin M (class IIb) of L. lactis (35).

To our knowledge, BlpGSt from S. thermophilus LMD-9 and BdbB from B. subtilis 168 (9) are the only examples of disulfide oxidases whose involvement in bacteriocin production has been demonstrated. However, their direct implication in the formation of disulfide bridges in the associated bacteriocin has never been shown. With the exception of the conserved thioredoxin motif (CXXC), the catalytic domain of BlpGSt differs significantly from those of BdbB (15% identity) and DsbA (30% identity). Higher similarities were observed to the catalytic domains of the putative thioredoxins BrcD (45% identity), Smu.1904c (64% identity), and Orf1 (60% identity), encoded in the class IIb bacteriocin loci involved in the production of brochocin C (33), mutacin V (19), and ABP-118 (14), respectively (Fig. 2A). Interestingly, these bacteriocins share structural features with BlpDSt*, BlpUSt*, and BlpESt*: these GA-rich peptides are predicted to form amphiphatic/hydrophobic {alpha} helices and to contain N- and C-terminal cysteine residues. Recently, the presence of one disulfide bridge was reported for BrcA (an {alpha} peptide of brochocin C) (17). In the present study, a correlation was observed between the presence of blpGSt in the producer strain and the antilisterial activity of thermophilin 9 (Table 3). Since only BlpDSt* seems to be required for the inhibition of Listeria strains, it can be speculated that BlpGSt is required for the formation of intra- and/or intermolecular disulfide bridges between the cysteine residues of BlpDSt*. These disulfide bridges might be important for the interaction of BlpDSt* with the membrane in Listeria species, whose lipid composition is known to differ significantly from that of LAB membranes (16).

Different mechanisms of immunity against bacteriocins have been reported. The immunity factors can either interact with the bacteriocin itself (e.g., NisI), thus preventing its interaction with the membrane, or actively export the intracellularly accumulated bacteriocins (e.g., NisFEG or Smu1913 in S. mutans) (5, 32). Recently, a novel mechanism was reported for class IIa and class IIc bacteriocins, in which the immunity peptides bind to the complex involving the bacteriocin and its membrane receptor, the mannose phosphotransferase (PTS) system (8). However, this PTS system does not seem to be involved in binding of thermophilin 9 to the target membrane, since a mutant of the indicator strain S. thermophilus LMG18311 in which the mannose PTS system was inactivated displayed the same level of sensitivity to the LMD-9 producer strain (data not shown). The structural similarities between Orf7 from S. thermophilus LMD-9 and Smu1913 from S. mutans (four predicted transmembrane domains and a large number of basic residues at the C-terminal end) might suggest a similar mode of action. Immunity against BlpDSt* could also occur through direct interactions of the Orf1, Orf2, and/or Orf7 peptide with BlpDSt*, which displays opposite charge properties (Table 1).

In conclusion, our results show that the blpDSt-orf2 operon encodes a functional bacteriocin/immunity module. A similar functional organization could be hypothesized for the blpUSt-orf3 and blpESt-blpFSt operons, although the cell target range of BlpUSt* and BlpESt*/BlpFSt* remains to be identified. The S. thermophilus strains used as indicator strains in this study all carry blpSt loci, which contain the blpABCSt and blpRHSt operons, as well as blpGSt (data not shown). The region located between blpRSt and blpGSt, which contains the bacteriocin/immunity determinants in strain LMD-9, is highly variable in size, between 2.5 kb (SFi16) and 4.5 kb (LMG7952). These strains also differ in the number and nature of the bacteriocin/immunity modules present in their blpSt loci: most strains carry only one bacteriocin operon (similar to blpDSt-orf2 or blpUSt-orf3), while LMG7952 bears two of these modules (similar to blpDSt-orf2 and blpESt-blpFSt). The presence of highly similar sequences upstream (blpRHSt) and downstream (blpGSt) of the bacteriocin/immunity modules, as well as the high sequence conservation between the promoter regions of all bacSt operons, suggests a plasticity mechanism for blpSt loci by the acquisition/loss of modules through homologous recombination, as proposed for the sakacin P cluster of L. sakei (34). The insertion element present in all sequenced clusters except that of LMD-9 might also play a role in this process. Finally, the modular nature of the blpSt locus offers interesting perspectives for the engineering of industrial LAB with the specific aim of inhibiting the growth of nonstarter strains or food-borne pathogen species, such as listeria.


arrow
ACKNOWLEDGMENTS
 
This research has been carried out with financial support from the Walloon Region (Bioval no. 981/3866 and -3845 and First Europe no. EPH3310300R0082) and FNRS. L.F. holds a doctoral fellowship from FRIA. P.H. is a research associate at FNRS.

We are grateful to E. Maguin and J. Kok for providing the pGhost9 and pMG36e vectors, respectively. We thank J. Mahillon and O. Minet for providing non-LAB indicator strains. E. coli strains AH50 and AH55 were kindly provided by J.-F. Collet. We thank P. Goffin and D. Prozzi for critically reading the manuscript. We warmly thank J. Delcour for fruitful discussions and scientific advice.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Unité de Génétique, Université catholique de Louvain, Place Croix du Sud 5, B-1348 Louvain-la-Neuve, Belgium. Phone: 32-10-478896. Fax: 32-10-473109. E-mail: hols{at}gene.ucl.ac.be Back

{triangledown} Published ahead of print on 21 December 2007. Back

{dagger} Supplemental material for this article may be found at http://aem.asm.org/. Back


arrow
REFERENCES
 
    1
  1. Allison, G. E., C. Fremaux, and T. R. Klaenhammer. 1994. Expansion of bacteriocin activity and host range upon complementation of two peptides encoded within the lactacin F operon. J. Bacteriol. 176:2235-2241.[Abstract/Free Full Text]
  2. 2
  3. Allison, G. E., and T. R. Klaenhammer. 1996. Functional analysis of the gene encoding immunity to lactacin F, lafI, and its use as a Lactobacillus-specific, food-grade genetic marker. Appl. Environ. Microbiol. 62:4450-4460.[Abstract]
  4. 3
  5. Bertin, P., E. Terao, E. H. Lee, P. Lejeune, C. Colson, A. Danchin, and E. Collatz. 1994. The H-NS protein is involved in the biogenesis of flagella in Escherichia coli. J. Bacteriol. 176:5537-5540.[Abstract/Free Full Text]
  6. 4
  7. Blomqvist, T., H. Steinmoen, and L. S. Havarstein. 2006. Pheromone-induced expression of recombinant proteins in Streptococcus thermophilus. Arch. Microbiol. 186:465-473.[CrossRef][Medline]
  8. 5
  9. Chatterjee, C., M. Paul, L. Xie, and W. A. van der Donk. 2005. Biosynthesis and mode of action of lantibiotics. Chem. Rev. 105:633-684.[CrossRef][Medline]
  10. 6
  11. Dailey, F. E., and H. C. Berg. 1993. Mutants in disulfide bond formation that disrupt flagellar assembly in Escherichia coli. Proc. Natl. Acad. Sci. USA 90:1043-1047.[Abstract/Free Full Text]
  12. 7
  13. de Ruyter, P. G., O. P. Kuipers, and W. M. de Vos. 1996. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl. Environ. Microbiol. 62:3662-3667.[Abstract]
  14. 8
  15. Diep, D. B., M. Skaugen, Z. Salehian, H. Holo, and I. F. Nes. 2007. Common mechanisms of target cell recognition and immunity for class II bacteriocins. Proc. Natl. Acad. Sci. USA 104:2384-2389.[Abstract/Free Full Text]
  16. 9
  17. Dorenbos, R., T. Stein, J. Kabel, C. Bruand, A. Bolhuis, S. Bron, W. J. Quax, and J. M. Van Dijl. 2002. Thiol-disulfide oxidoreductases are essential for the production of the lantibiotic sublancin 168. J. Biol. Chem. 277:16682-16688.[Abstract/Free Full Text]
  18. 10
  19. Dower, W. J., J. F. Miller, and C. W. Ragsdale. 1988. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res. 16:6127-6145.[Abstract/Free Full Text]
  20. 11
  21. Eijsink, V. G., M. Skeie, P. H. Middelhoven, M. B. Brurberg, and I. F. Nes. 1998. Comparative studies of class IIa bacteriocins of lactic acid bacteria. Appl. Environ. Microbiol. 64:3275-3281.[Abstract/Free Full Text]
  22. 12
  23. Ennahar, S., K. Sonomoto, and A. Ishizaki. 1999. Class IIa bacteriocins from lactic acid bacteria: antibacterial activity and food preservation. J. Biosci. Bioeng. 87:705-716.[CrossRef][Medline]
  24. 13
  25. Ferain, T., J. N. Hobbs, Jr., J. Richardson, N. Bernard, D. Garmyn, P. Hols, N. E. Allen, and J. Delcour. 1996. Knockout of the two ldh genes has a major impact on peptidoglycan precursor synthesis in Lactobacillus plantarum. J. Bacteriol. 178:5431-5437.[Abstract/Free Full Text]
  26. 14
  27. Flynn, S., D. van Sinderen, G. M. Thornton, H. Holo, I. F. Nes, and J. K. Collins. 2002. Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118. Microbiology 148:973-984.[Abstract/Free Full Text]
  28. 15
  29. Fontaine, L., C. Boutry, E. Guedon, A. Guillot, M. Ibrahim, B. Grossiord, and P. Hols. 2007. Quorum-sensing regulation of the production of Blp bacteriocins in Streptococcus thermophilus. J. Bacteriol. 189:7195-7205.[Abstract/Free Full Text]
  30. 16
  31. Gandhi, M., and M. L. Chikindas. 2007. Listeria: a foodborne pathogen that knows how to survive. Int. J. Food Microbiol. 113:1-15.[CrossRef][Medline]
  32. 17
  33. Garneau, S., C. A. Ference, M. J. van Belkum, M. E. Stiles, and J. C. Vederas. 2003. Purification and characterization of brochocin A and brochocin B(10-43), a functional fragment generated by heterologous expression in Carnobacterium piscicola. Appl. Environ. Microbiol. 69:1352-1358.[Abstract/Free Full Text]
  34. 18
  35. Garneau, S., N. I. Martin, and J. C. Vederas. 2002. Two-peptide bacteriocins produced by lactic acid bacteria. Biochimie 84:577-592.[Medline]
  36. 19
  37. Hale, J. D., Y. T. Ting, R. W. Jack, J. R. Tagg, and N. C. Heng. 2005. Bacteriocin (mutacin) production by Streptococcus mutans genome sequence reference strain UA159: elucidation of the antimicrobial repertoire by genetic dissection. Appl. Environ. Microbiol. 71:7613-7617.[Abstract/Free Full Text]
  38. 20
  39. Hechard, Y., and H. G. Sahl. 2002. Mode of action of modified and unmodified bacteriocins from gram-positive bacteria. Biochimie 84:545-557.[Medline]
  40. 21
  41. Hiniker, A., J. F. Collet, and J. C. Bardwell. 2005. Copper stress causes an in vivo requirement for the Escherichia coli disulfide isomerase DsbC. J. Biol. Chem. 280:33785-33791.[Abstract/Free Full Text]
  42. 22
  43. Hols, P., F. Hancy, L. Fontaine, B. Grossiord, D. Prozzi, N. Leblond-Bourget, B. Decaris, A. Bolotin, C. Delorme, E. S. Dusko, E. Guedon, V. Monnet, P. Renault, and M. Kleerebezem. 2005. New insights in the molecular biology and physiology of Streptococcus thermophilus revealed by comparative genomics. FEMS Microbiol. Rev. 29:435-463.[CrossRef][Medline]
  44. 23
  45. Kamiya, R. U., M. H. Napimoga, R. T. Rosa, J. F. Hofling, and R. B. Goncalves. 2005. Mutacin production in Streptococcus mutans genotypes isolated from caries-affected and caries-free individuals. Oral Microbiol. Immunol. 20:20-24.[CrossRef][Medline]
  46. 24
  47. Klaenhammer, T. R. 1988. Bacteriocins of lactic acid bacteria. Biochimie 70:337-349.[Medline]
  48. 25
  49. Kleerebezem, M., and L. E. Quadri. 2001. Peptide pheromone-dependent regulation of antimicrobial peptide production in Gram-positive bacteria: a case of multicellular behavior. Peptides 22:1579-1596.[CrossRef][Medline]
  50. 26
  51. Law, J., G. Buist, A. Haandrikman, J. Kok, G. Venema, and K. Leenhouts. 1995. A system to generate chromosomal mutations in Lactococcus lactis which allows fast analysis of targeted genes. J. Bacteriol. 177:7011-7018.[Abstract/Free Full Text]
  52. 27
  53. Leenhouts, K. J., J. Kok, and G. Venema. 1991. Replacement recombination in Lactococcus lactis. J. Bacteriol. 173:4794-4798.[Abstract/Free Full Text]
  54. 28
  55. Maguin, E., P. Duwat, T. Hege, D. Ehrlich, and A. Gruss. 1992. New thermosensitive plasmid for gram-positive bacteria. J. Bacteriol. 174:5633-5638.[Abstract/Free Full Text]
  56. 29
  57. Maguin, E., H. Prevost, S. D. Ehrlich, and A. Gruss. 1996. Efficient insertional mutagenesis in lactococci and other gram-positive bacteria. J. Bacteriol. 178:931-935.[Abstract/Free Full Text]
  58. 30
  59. Marciset, O., M. C. Jeronimus-Stratingh, B. Mollet, and B. Poolman. 1997. Thermophilin 13, a nontypical antilisterial poration complex bacteriocin, that functions without a receptor. J. Biol. Chem. 272:14277-14284.[Abstract/Free Full Text]
  60. 31
  61. Mathiesen, G., K. Huehne, L. Kroeckel, L. Axelsson, and V. G. Eijsink. 2005. Characterization of a new bacteriocin operon in sakacin P-producing Lactobacillus sakei, showing strong translational coupling between the bacteriocin and immunity genes. Appl. Environ. Microbiol. 71:3565-3574.[Abstract/Free Full Text]
  62. 32
  63. Matsumoto-Nakano, M., and H. K. Kuramitsu. 2006. Role of bacteriocin immunity proteins in the antimicrobial sensitivity of Streptococcus mutans. J. Bacteriol. 188:8095-8102.[Abstract/Free Full Text]
  64. 33
  65. McCormick, J. K., A. Poon, M. Sailer, Y. Gao, K. L. Roy, L. M. McMullen, J. C. Vederas, M. E. Stiles, and M. J. van Belkum. 1998. Genetic characterization and heterologous expression of brochocin-C, an antibotulinal, two-peptide bacteriocin produced by Brochothrix campestris ATCC 43754. Appl. Environ. Microbiol. 64:4757-4766.[Abstract/Free Full Text]
  66. 34
  67. Moretro, T., K. Naterstad, E. Wang, I. M. Aasen, S. Chaillou, M. Zagorec, and L. Axelsson. 2005. Sakacin P non-producing Lactobacillus sakei strains contain homologues of the sakacin P gene cluster. Res. Microbiol. 156:949-960.[Medline]
  68. 35
  69. Morgan, S., R. P. Ross, and C. Hill. 1995. Bacteriolytic activity caused by the presence of a novel lactococcal plasmid encoding lactococcins A, B, and M. Appl. Environ. Microbiol. 61:2995-3001.[Abstract]
  70. 36
  71. Nes, I. F., and H. Holo. 2000. Class II antimicrobial peptides from lactic acid bacteria. Biopolymers 55:50-61.[CrossRef][Medline]
  72. 37
  73. Richard, C., R. Canon, K. Naghmouchi, D. Bertrand, H. Prevost, and D. Drider. 2006. Evidence on correlation between number of disulfide bridge and toxicity of class IIa bacteriocins. Food Microbiol. 23:175-183.[CrossRef][Medline]
  74. 38
  75. Sambrook, J., E. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  76. 39
  77. Tichaczek, P. S., R. F. Vogel, and W. P. Hammes. 1994. Cloning and sequencing of sakP encoding sakacin P, the bacteriocin produced by Lactobacillus sake LTH 673. Microbiology 140:361-367.[Abstract/Free Full Text]
  78. 40
  79. van de Guchte, M., J. M. van der Vossen, J. Kok, and G. Venema. 1989. Construction of a lactococcal expression vector: expression of hen egg white lysozyme in Lactococcus lactis subsp. lactis. Appl. Environ. Microbiol. 55:224-228.[Abstract/Free Full Text]


Applied and Environmental Microbiology, February 2008, p. 1102-1110, Vol. 74, No. 4
0099-2240/08/$08.00+0     doi:10.1128/AEM.02030-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fontaine, L.
Right arrow Articles by Hols, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fontaine, L.
Right arrow Articles by Hols, P.
Agricola
Right arrow Articles by Fontaine, L.
Right arrow Articles by Hols, P.